Cargando…

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)

Detalles Bibliográficos
Autores principales:	Schildgen, Verena, Lüsebrink, Jessica, Schildgen, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135481/ https://www.ncbi.nlm.nih.gov/pubmed/35664836 http://dx.doi.org/10.1016/j.nmni.2022.100987

Ejemplares similares

Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnerable individuals
por: Schildgen, Verena, et al.
Publicado: (2022)

Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way out
por: Schildgen, Verena, et al.
Publicado: (2023)

Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)
por: Lüsebrink, Jessica, et al.
Publicado: (2020)

Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective
por: Schildgen, Verena, et al.
Publicado: (2021)

Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination
por: Hsu, Lea, et al.
Publicado: (2021)

Direct comparison of Altona-SARS-CoV-2 dual target RT-qPCR Assay with commercial LAMP Assay using throat washes in health care staff testing
por: Wanney, Johannes, et al.
Publicado: (2022)

Human Bocavirus – Insights into a Newly Identified Respiratory Virus
por: Lüsebrink, Jessica, et al.
Publicado: (2009)

Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals
por: Ditt, Vanessa, et al.
Publicado: (2011)

NGS-dataset of putative driver mutations associated with benign peritoneal strumosis
por: Brockmann, Michael, et al.
Publicado: (2018)

Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes
por: Schildgen, Verena, et al.
Publicado: (2011)

Detailed overview on the mutations detected by and the sensitivity of the GeneReader NGS sequencing platform
por: Lüsebrink, Jessica, et al.
Publicado: (2018)

Low Titer Pneumocystis jirovecii Infections: More than Just Colonization?
por: Prickartz, Alexander, et al.
Publicado: (2016)

Detection of Head-to-Tail DNA Sequences of Human Bocavirus in Clinical Samples
por: Lüsebrink, Jessica, et al.
Publicado: (2011)

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
por: Kuhlmann, Constanze, et al.
Publicado: (2022)

Comparison of Two Commercial PCR Methods for Methicillin-Resistant Staphylococcus aureus (MRSA) Screening in a Tertiary Care Hospital
por: Aydiner, Aylin, et al.
Publicado: (2012)

Pneumocystis jirovecii Can Be Productively Cultured in Differentiated CuFi-8 Airway Cells
por: Schildgen, Verena, et al.
Publicado: (2014)

SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household
por: Yi, Seonju, et al.
Publicado: (2021)

A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
por: Zhang, Mengxin, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden
por: Kretschmer, Andreas, et al.
Publicado: (2022)

Differential cytology profiles in bronchoalveolar lavage (BAL) in COVID-19 patients: A descriptive observation and comparison with other corona viruses, Influenza virus, Haemophilus influenzae, and Pneumocystis jirovecii
por: Vedder, Vanessa, et al.
Publicado: (2021)

Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward
por: Wi, Yu Mi, et al.
Publicado: (2022)

Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections
por: Farinholt, Timothy, et al.
Publicado: (2021)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
por: Goto, Takeyuki, et al.
Publicado: (2022)

SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations
por: Platten, Martin, et al.
Publicado: (2021)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
por: Shastri, Jayanthi, et al.
Publicado: (2021)

Are booster shots coming?
por: Lawton, Graham
Publicado: (2021)

Does human bocavirus infection depend on helper viruses? A challenging case report
por: Streiter, Monika, et al.
Publicado: (2011)

Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy
por: Baj, Andreina, et al.
Publicado: (2021)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
por: Santi, Theresia, et al.
Publicado: (2022)

Diagnostic stumbling blocks in the COVID-19 monitoring of medical staff while putting hygiene requirements into practice
por: Schildgen, V., et al.
Publicado: (2020)

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c1013t9vqq1ggj51nv3mjvb319